Skip to content
All Podcasts – Lifestyle
Author:
Amplia Therapeutics Limited
Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities for Combination with KRAS Inhibition in Pancreatic Cancer
June 22, 2026